Simple Summary Cancer remains one of the leading causes of death worldwide, which
emphasizes the need for its early and accurate diagnosis and prognosis. Our review …

Motivation In this article, we consider how to evaluate survival distribution predictions with
measures of discrimination. This is non-trivial as discrimination measures are the most …

Abstract The International Staging System (ISS) and the Revised International Staging
System (R-ISS) are commonly used prognostic scores in multiple myeloma (MM). These …

Despite the improvements in clinical outcomes for DLBCL, a significant proportion of
patients still face challenges with refractory/relapsed (R/R) disease after receiving first-line R …

Machine learning (ML) approaches have been applied in the diagnosis and prediction of
haematological malignancies. The consideration of ML algorithms to complement or replace …

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of affected …

Objectives Early discontinuation is common among breast cancer patients taking aromatase
inhibitors (AIs). Although several predictors have been identified, it is unclear how to …

Follicular Lymphoma (FL) has a 10-year mortality rate of 20%, and this is mostly related to
lymphoma progression and transformation to higher grades. In the era of personalized …

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of aggressive lymphoma.
Approximately 60% of fit patients achieve curation with immunochemotherapy, but the …

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin
lymphoma (NHL) and is characterized by high heterogeneity. Assessment of its prognosis …